<p>BALB/c mice were immunized ID with 10<sup>5</sup> CFU of LVS (square; n = 12) or FSC200<i>ΔclpB</i> (circle; n = 17) and challenged 6 weeks later IN with 86 CFU of SCHU S4. <b>*</b>, Significantly longer survival than mice immunized with LVS.</p
<p>Mice were either orally vaccinated with 10<sup>10</sup> BRD509 (⬜) or IV vaccinated with 10<sup>2...
a<p>In experiment 1 (Exp. 1), WT C57BL/6J mice or IL-23 KO mice (either p19M KO or p19G KO mice, as ...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>BALB/c mice (n = 5/group) were immunized with 10<sup>3</sup> (squares), 10<sup>5</sup> (circles),...
<p>Mice (n = 5) were vaccinated i.d. (A) or i.n. (B) with 10-fold serial dilutions of Schu S4 Δ<i>pu...
<p>Mice were immunized on day 0, 14 and 28 with DnaK+GPI, Tul4+GPI or DnaK+Tul4+GPI. Control groups ...
a<p>Mice were immunized with either LVS or ΔFTL_0883 at the indicated dose and then challenged with ...
<p>C57BL/6J mice were immunized by ID infection with 1×10<sup>4</sup> CFU LVS, 1×10<sup>8</sup> HK-L...
<p>BALB/c mice (n = 4/group) were immunized ID with ∼10<sup>5</sup> CFU of FSC200 <i>ΔclpB</i> (circ...
<p>Groups of BALB/c mice (n = 10) were administered one (dark bars) or two doses (light bars) of fCV...
<p>BALB/c mice (n = 4/group) were immunized ID with ∼10<sup>5</sup> CFU of FSC200 <i>ΔclpB</i> (circ...
<p>Blue asterisk, significantly greater survival than control mice or mice immunized with LVS; green...
<p>Mice were immunized with 50 μg of DNA vaccine intramuscularly via EP followed by two boosters wit...
<p>The remaining naïve, and LVSCE, LVSCE/AMVAD or LVSCE/CT immunized groups of mice (n = 15) in <a h...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>Mice were either orally vaccinated with 10<sup>10</sup> BRD509 (⬜) or IV vaccinated with 10<sup>2...
a<p>In experiment 1 (Exp. 1), WT C57BL/6J mice or IL-23 KO mice (either p19M KO or p19G KO mice, as ...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>BALB/c mice (n = 5/group) were immunized with 10<sup>3</sup> (squares), 10<sup>5</sup> (circles),...
<p>Mice (n = 5) were vaccinated i.d. (A) or i.n. (B) with 10-fold serial dilutions of Schu S4 Δ<i>pu...
<p>Mice were immunized on day 0, 14 and 28 with DnaK+GPI, Tul4+GPI or DnaK+Tul4+GPI. Control groups ...
a<p>Mice were immunized with either LVS or ΔFTL_0883 at the indicated dose and then challenged with ...
<p>C57BL/6J mice were immunized by ID infection with 1×10<sup>4</sup> CFU LVS, 1×10<sup>8</sup> HK-L...
<p>BALB/c mice (n = 4/group) were immunized ID with ∼10<sup>5</sup> CFU of FSC200 <i>ΔclpB</i> (circ...
<p>Groups of BALB/c mice (n = 10) were administered one (dark bars) or two doses (light bars) of fCV...
<p>BALB/c mice (n = 4/group) were immunized ID with ∼10<sup>5</sup> CFU of FSC200 <i>ΔclpB</i> (circ...
<p>Blue asterisk, significantly greater survival than control mice or mice immunized with LVS; green...
<p>Mice were immunized with 50 μg of DNA vaccine intramuscularly via EP followed by two boosters wit...
<p>The remaining naïve, and LVSCE, LVSCE/AMVAD or LVSCE/CT immunized groups of mice (n = 15) in <a h...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>Mice were either orally vaccinated with 10<sup>10</sup> BRD509 (⬜) or IV vaccinated with 10<sup>2...
a<p>In experiment 1 (Exp. 1), WT C57BL/6J mice or IL-23 KO mice (either p19M KO or p19G KO mice, as ...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...